Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the resources section.SummaryDifference0.2%

- Check8 days agoChange Detected- Revision label updated to v3.4.3. References to 'Multiple Myeloma', related topics such as 'MedlinePlus Genetics', and the older 'Revision: v3.4.2' were removed from the related topics.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded core topic tag 'Multiple myeloma' and related topic 'MedlinePlus Genetics'. Updated page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1; there are no substantive changes to trial details or on-page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedDeleted the 'Multiple Myeloma' topic and related 'MedlinePlus Genetics' topics from the page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page shows a minor revision note updating from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.